PD-1 blockade in combination with dasatinib potentiates induction of anti-acute lymphocytic leukemia immunity.
Koller P, Baran N, Harutyunyan K, Cavazos A, Mallampati S, Chin RL, Jiang Z, Sun X, Lee HH, Hsu JL, Williams P, Huang X, Curran MA, Hung MC, Konopleva M.
Koller P, et al. Among authors: cavazos a.
J Immunother Cancer. 2023 Oct;11(10):e006619. doi: 10.1136/jitc-2022-006619.
J Immunother Cancer. 2023.
PMID: 37793852
Free PMC article.